Ginkgo Bioworks Holdings (DNA) Profit After Tax (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Profit After Tax of -$82.6 million for Q1 2026, down 135.62% on a QoQ basis from $231.9 million in Q4 2025, and up 0.87% year-over-year from -$81.9 million in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Profit After Tax (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Profit After Tax history runs 7 years deep, the most recent figure standing at -$82.6 million for Q1 2026.
- Quarterly Profit After Tax rose 0.87% year-over-year to -$82.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.7 million (down 86.65% YoY) and the FY2025 annual result came in at $3.7 million, up 211.16% from the prior year.
- Profit After Tax was -$82.6 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $231.9 million in the prior quarter.
- Across five years, Profit After Tax topped out at $437.4 million in Q4 2024 and bottomed at -$670.6 million in Q2 2022.
- A 5-year average of -$180.8 million and a median of -$173.0 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax sank 1143.15% — and 2024, when it jumped 306.63%.
- Ginkgo Bioworks Holdings' Profit After Tax stood at -$175.5 million in 2022, then declined by 20.65% to -$211.7 million in 2023, then soared by 306.63% to $437.4 million in 2024, then slumped by 46.99% to $231.9 million in 2025, then plunged by 135.62% to -$82.6 million in 2026.
- Business Quant data shows DNA's Profit After Tax at -$82.6 million in Q1 2026, $231.9 million in Q4 2025, and -$80.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | -82.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.59 Mn |
| Dec 31, 2025 | 231.87 Mn |
| Sep 30, 2025 | -80.76 Mn |
| Jun 30, 2025 | -57.80 Mn |
| Mar 31, 2025 | -83.31 Mn |
| Dec 31, 2024 | 437.43 Mn |
| Sep 30, 2024 | -56.40 Mn |
| Jun 30, 2024 | -217.35 Mn |
| Mar 31, 2024 | -165.91 Mn |
| Dec 31, 2023 | -211.69 Mn |
| Sep 30, 2023 | -302.89 Mn |
| Jun 30, 2023 | -173.00 Mn |
| Mar 31, 2023 | -203.95 Mn |
| Dec 31, 2022 | -175.47 Mn |
| Sep 30, 2022 | -670.13 Mn |
| Jun 30, 2022 | -670.57 Mn |
| Mar 31, 2022 | -590.51 Mn |
| Dec 31, 2021 | -1.61 Bn |
| Sep 30, 2021 | -102.41 Mn |
| Jun 30, 2021 | -53.94 Mn |